+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Drug Delivery Devices Market Size, Share & Trends Analysis Report by Product (Inhalers, Injection Devices, Transdermal Patches), Application (Oncology, Infectious Diseases, Respiratory Diseases, Diabetes), End Use, and Region with Growth Forecasts, 2026-2033

  • PDF Icon

    Report

  • 200 Pages
  • December 2025
  • Region: Global
  • Grand View Research
  • ID: 5914568
REQUEST CUSTOMIZATION
Description Jump to:
The global drug delivery devices market size was valued at USD 463.8 billion in 2025 and is projected to reach USD 841.4 billion by 2033, growing at a CAGR of 7.8% from 2026 to 2033. The growing adoption of advanced technology for precise drug delivery is driving market expansion.

In June 2024, Aptar Digital Health and SHL Medical partnered to enhance injectable therapy experiences by integrating Aptar’s SaMD platform with SHL’s connected drug delivery solutions, including the Molly Connected Cap. This collaboration aims to improve self-injection therapy through digital health innovations. These devices optimize the connected drug delivery devices market, minimizing dosage and side effects, which lowers costs by reducing active pharmaceutical ingredient use. The novel drug delivery devices market is also anticipated to witness accelerated R&D efforts owing to rising demand.

Drug delivery devices are used for conditions such as asthma, chronic obstructive pulmonary disease (COPD), diabetes, cancer, cardiovascular diseases, and chronic pain. These devices ensure precise, targeted delivery of medications, improving efficacy and patient compliance while minimizing side effects. According to the Asthma and Allergy Foundation of America, Asthma affects over 27 million people in the U.S., roughly 1 in 12 individuals. Among adults aged 18 and older, over 22 million have asthma, with a higher prevalence in females (10.8%) compared to males (6.5%). Asthma ranks among the most common and expensive diseases in the U.S. For instance, according to National Asthma Council Australia Ltd, the Salflumix Easyhaler, added to the Pharmaceutical Benefits Scheme (PBS) on April 1, 2024, treats asthma and COPD with fluticasone propionate/salmeterol in two strengths: 250/50 and 500/50. It is a dry powder inhaler that requires shaking before use and has a dose counter. The Easyhaler is suitable for various ages and disease severities. In addition, it is entirely carbon neutral.

The rising elderly population has heightened the need for subcutaneous devices for diagnosing and treating various chronic health conditions. Studies indicate that individuals aged 65 and older face increased risks of serious ailments such as heart disease, asthma, respiratory infections, COPD, diabetes, and other disorders, as aging weakens the immune system, thus driving the subcutaneous drug delivery devices market.

Global Drug Delivery Devices Market Report Segmentation

This report forecasts revenue growth at global, regional and country levels and provides an analysis of the latest industry trends and opportunities in each of the sub-segments from 2021 to 2033. The report has segmented the global drug delivery devices market report on the basis of product, application, end use, and region:

Product Outlook (Revenue, USD Million, 2021-2033)

  • Inhalers
  • Injection Devices
  • Implants
  • Topical Delivery System
  • Oral Delivery System
  • Occular Delivery System
  • Nebulizers
  • Transdermal Patches
  • Infusion Pumps

Application Outlook (Revenue, USD Million, 2021-2033)

  • Oncology
  • Infectious Diseases
  • Respiratory Diseases
  • Diabetes
  • Cardiovascular Diseases
  • Autoimmune Diseases
  • Central Nervous System Disorders
  • Others

End Use Outlook (Revenue, USD Million, 2021-2033)

  • Hospitals
  • Diagnostic Centers
  • Ambulatory Surgery Centers/Clinics
  • Home Care Settings
  • Others

Region Outlook (Revenue, USD Million, 2021-2033)

  • North America
  • Europe
  • Asia-Pacific
  • Latin America
  • Middle East & Africa

Why You Should Buy This Report

  • Comprehensive Market Analysis: Gain detailed insights into the market across major regions and segments.
  • Competitive Landscape: Explore the market presence of key players.
  • Future Trends: Discover the pivotal trends and drivers shaping the future of the market.
  • Actionable Recommendations: Utilize insights to uncover new revenue streams and guide strategic business decisions.

This report addresses:

  • Market intelligence to enable effective decision-making
  • Market estimates and forecasts from 2018 to 2030
  • Growth opportunities and trend analyses
  • Segment and regional revenue forecasts for market assessment
  • Competition strategy and market share analysis
  • Product innovation listings for you to stay ahead of the curve

This product will be delivered within 1-3 business days.

Table of Contents

Chapter 1. Methodology and Scope
1.1. Market Segmentation and Scope
1.1.1 Segment Definitions
1.1.2. Product
1.1.3. Application
1.1.4. End-use
1.1.5. Regional scope
1.1.6. Estimates and forecasts timeline
1.2. Research Methodology
1.3. Information Procurement
1.3.1. Purchased database
1.3.2. internal database
1.3.3. Secondary sources
1.3.4. Primary research
1.3.5. Details of primary research
1.3.5.1. Data for primary interviews in North America
1.3.5.2. Data for primary interviews in Europe
1.3.5.3. Data for primary interviews in Asia-Pacific
1.3.5.4. Data for primary interviews in Latin America
1.3.5.5. Data for Primary interviews in MEA
1.4. Information or Data Analysis
1.4.1. Data analysis models
1.5. Market Formulation & Validation
1.6. Model Details
1.6.1. Commodity flow analysis (Model 1)
1.6.2. Approach 1: Commodity flow approach
1.6.3. Volume price analysis (Model 2)
1.6.4. Approach 2: Volume price analysis
1.7. List of Secondary Sources
1.8. List of Primary Sources
1.9. Objectives
Chapter 2. Executive Summary
2.1. Market Outlook
2.2. Segment Outlook
2.2.1. Product outlook
2.2.2. Application outlook
2.2.3. End use outlook
2.3. Regional outlook
2.4. Competitive Insights
Chapter 3. Drug Delivery Devices Market Variables, Trends & Scope
3.1. Market Lineage Outlook
3.1.1. Parent Market Outlook
3.1.2. Related/ancillary market outlook
3.2. Market Dynamics
3.2.1. Market Driver Analysis
3.2.1.1. Growing demand for novel drug delivery devices
3.2.1.2. Increasing prevalence of chronic diseases
3.2.1.3. Technological advancement in drug delivery devices
3.2.1.4. Growing strategic alliances for drug delivery devices
3.2.2. Market Restraint Analysis
3.2.2.1. Challenges associated with various routes of drug delivery devices
3.3. Drug Delivery Devices Market Analysis Tools
3.3.1. Industry Analysis - Porter’s
3.3.1.1. Bargaining power of suppliers
3.3.1.2. Bargaining power of buyers
3.3.1.3. Threat of substitutes
3.3.1.4. Threat of new entrants
3.3.1.5. Competitive rivalry
3.3.2. PESTEL Analysis
3.3.2.1. Political landscape
3.3.2.2. Economic landscape
3.3.2.3. Social landscape
3.3.2.4. Technological landscape
3.3.2.5. Environmental landscape
3.3.2.6. Legal landscape
Chapter 4. Drug Delivery Devices Market: Product Estimates & Trend Analysis
4.1. Segment Dashboard
4.2. Drug Delivery Devices Market: Product Movement Analysis
4.3. Drug Delivery Devices Market by Product Outlook (USD Million)
4.4. Market Size & Forecasts and Trend Analyses, 2021 to 2033 for the following
4.5. Inhalers
4.5.1. Inhalers Market Revenue Estimates and Forecasts, 2021-2033 (USD Million)
4.5.1.1. Metered-dose inhalers (MDIs)
4.5.1.1.1. Metered-dose inhalers (MDIs) Market Revenue Estimates and Forecasts, 2021-2033 (USD Million)
4.5.1.2. Dry powder inhalers (DPIs)
4.5.1.2.1. Dry powder inhalers (DPIs) Market Revenue Estimates and Forecasts, 2021-2033 (USD Million)
4.5.1.3. Others
4.5.1.3.1. Others Market Revenue Estimates and Forecasts, 2021-2033 (USD Million)
4.6. Injection Devices
4.6.1. Injection Devices Market Revenue Estimates and Forecasts, 2021-2033 (USD Million)
4.6.1.1. Prefilled Syringes
4.6.1.1.1. Prefilled Syringes Market Revenue Estimates and Forecasts, 2021-2033 (USD Million)
4.6.1.2. Auto-injectors
4.6.1.2.1. Auto-injectors Market Revenue Estimates and Forecasts, 2021-2033 (USD Million)
4.6.1.3. Pen Injectors
4.6.1.3.1. Pen Injectors Market Revenue Estimates and Forecasts, 2021-2033 (USD Million)
4.6.1.4. Needle-free Injectors
4.6.1.4.1. Needle-free Injectors Market Revenue Estimates and Forecasts, 2021-2033 (USD Million)
4.6.1.5. Wearable Injectors
4.6.1.5.1. Wearable Injectors Market Revenue Estimates and Forecasts, 2021-2033 (USD Million)
4.7. Implants
4.7.1. Implants Market Revenue Estimates and Forecasts, 2021-2033 (USD Million)
4.7.1.1. Contraceptive Implants
4.7.1.1.1. Contraceptive Implants Market Revenue Estimates and Forecasts, 2021-2033 (USD Million)
4.7.1.2. Drug-eluting Stents
4.7.1.2.1. Drug-eluting Stents Market Revenue Estimates and Forecasts, 2021-2033 (USD Million)
4.7.1.3. Biodegradable Implants
4.7.1.3.1. Biodegradable Implants Market Revenue Estimates and Forecasts, 2021-2033 (USD Million)
4.8. Topical Delivery System
4.8.1. Topical Delivery System Market Revenue Estimates and Forecasts, 2021-2033 (USD Million)
4.8.1.1. Creams
4.8.1.1.1. Creams Market Revenue Estimates and Forecasts, 2021-2033 (USD Million)
4.8.1.2. Gels
4.8.1.2.1. Gels Market Revenue Estimates and Forecasts, 2021-2033 (USD Million)
4.8.1.3. Ointments
4.8.1.3.1. Ointments Market Revenue Estimates and Forecasts, 2021-2033 (USD Million)
4.9. Oral Delivery System
4.9.1. Oral Delivery System Market Revenue Estimates and Forecasts, 2021-2033 (USD Million)
4.9.1.1. Controlled-release Tablets and Capsules
4.9.1.1.1. Controlled-release Tablets and Capsules Market Revenue Estimates and Forecasts, 2021-2033 (USD Million)
4.9.1.2. Buccal and Sublingual Tablets
4.9.1.2.1. Buccal and Sublingual Tablets Market Revenue Estimates and Forecasts, 2021-2033 (USD Million)
4.10. Occular Delivery System
4.10.1. Occular Delivery System Market Revenue Estimates and Forecasts, 2021-2033 (USD Million)
4.11. Nebulizers
4.11.1. Nebulizers Market Revenue Estimates and Forecasts, 2021-2033 (USD Million)
4.12. Transdermal Patches
4.12.1. Transdermal Patches Market Revenue Estimates and Forecasts, 2021-2033 (USD Million)
4.13. Infusion Pumps
4.13.1. Infusion Pumps Market Revenue Estimates and Forecasts, 2021-2033 (USD Million)
Chapter 5. Drug Delivery Devices Market: Application Estimates & Trend Analysis
5.1. Segment Dashboard
5.2. Drug Delivery Devices Market: Application Movement Analysis
5.3. Drug Delivery Devices Market by Application Outlook (USD Million)
5.4. Market Size & Forecasts and Trend Analyses, 2021 to 2033 for the following
5.5. Oncology
5.5.1. Oncology Market Revenue Estimates and Forecasts, 2021-2033 (USD Million)
5.6. Infectious Diseases
5.6.1. Infectious Diseases Market Revenue Estimates and Forecasts, 2021-2033 (USD Million)
5.7. Respiratory Diseases
5.7.1. Respiratory Diseases Market Revenue Estimates and Forecasts, 2021-2033 (USD Million)
5.8. Diabetes
5.8.1. Diabetes Market Revenue Estimates and Forecasts, 2021-2033 (USD Million)
5.9. Cardiovascular Diseases
5.9.1. Cardiovascular Diseases Market Revenue Estimates and Forecasts, 2021-2033 (USD Million)
5.10. Autoimmune Diseases
5.10.1. Autoimmune Diseases Market Revenue Estimates and Forecasts, 2021-2033 (USD Million)
5.11. Central Nervous System Disorders
5.11.1. Central Nervous System Disorders Market Revenue Estimates and Forecasts, 2021-2033 (USD Million)
5.12. Others
5.12.1. Others Market Revenue Estimates and Forecasts, 2021-2033 (USD Million)
Chapter 6. Drug Delivery Devices Market: End-use Estimates & Trend Analysis
6.1. Segment Dashboard
6.2. Drug Delivery Devices Market: End-use Movement Analysis
6.3. Drug Delivery Devices Market by End-use Outlook (USD Million)
6.4. Market Size & Forecasts and Trend Analyses, 2021 to 2033 for the following
6.5. Hospitals
6.5.1. Hospitals Market Revenue Estimates and Forecasts, 2021-2033 (USD Million)
6.6. Diagnostic Centers
6.6.1. Diagnostic Centers Market Revenue Estimates and Forecasts, 2021-2033 (USD Million)
6.7. Ambulatory Surgery Centers/Clinics
6.7.1. Ambulatory Surgery Centers/Clinics Market Revenue Estimates and Forecasts, 2021-2033 (USD Million)
6.8. Home Care Settings
6.8.1. Home Care Settings Market Revenue Estimates and Forecasts, 2021-2033 (USD Million)
6.9. Others
6.9.1. Others Market Revenue Estimates and Forecasts, 2021-2033 (USD Million)
Chapter 7. Drug Delivery Devices Market: Regional Estimates & Trend Analysis
7.1. Regional Dashboard
7.2. Regional Drug Delivery Devices Market Movement Analysis
7.3. Drug Delivery Devices Market: Regional Estimates & Trend Analysis by Distribution Channel & End-use
7.4. Market Size & Forecasts and Trend Analyses, 2021 to 2033 for the following
7.5. North America
7.5.1. North America Drug Delivery Devices Market Estimates and Forecasts, 2021-2033 (USD Million)
7.5.2. U.S.
7.5.2.1. Key Country Dynamics
7.5.2.2. Competitive Scenario
7.5.2.3. Regulatory Framework
7.5.2.4. Reimbursement scenario
7.5.2.5. U.S. Drug Delivery Devices Market Estimates and Forecasts, 2021-2033 (USD Million)
7.5.3. Canada
7.5.3.1. Key Country Dynamics
7.5.3.2. Competitive Scenario
7.5.3.3. Regulatory Framework
7.5.3.4. Reimbursement scenario
7.5.3.5. Canada Drug Delivery Devices Market Estimates and Forecasts, 2021-2033 (USD Million)
7.5.4. Mexico
7.5.4.1. Key Country Dynamics
7.5.4.2. Competitive Scenario
7.5.4.3. Regulatory Framework
7.5.4.4. Reimbursement scenario
7.5.4.5. Mexico Drug Delivery Devices Market Estimates and Forecasts, 2021-2033 (USD Million)
7.5.5. Europe
7.5.6. Europe Drug Delivery Devices Market Estimates and Forecasts, 2021-2033 (USD Million)
7.5.7. UK
7.5.7.1. Key Country Dynamics
7.5.7.2. Competitive Scenario
7.5.7.3. Regulatory Framework
7.5.7.4. Reimbursement scenario
7.5.7.5. UK Drug Delivery Devices Market Estimates and Forecasts, 2021-2033 (USD Million)
7.5.8. Germany
7.5.8.1. Key Country Dynamics
7.5.8.2. Competitive Scenario
7.5.8.3. Regulatory Framework
7.5.8.4. Reimbursement scenario
7.5.8.5. Germany Drug Delivery Devices Market Estimates and Forecasts, 2021-2033 (USD Million)
7.5.9. France
7.5.9.1. Key Country Dynamics
7.5.9.2. Competitive Scenario
7.5.9.3. Regulatory Framework
7.5.9.4. Reimbursement scenario
7.5.9.5. France Drug Delivery Devices Market Estimates and Forecasts, 2021-2033 (USD Million)
7.5.10. Italy
7.5.10.1. Key Country Dynamics
7.5.10.2. Competitive Scenario
7.5.10.3. Regulatory Framework
7.5.10.4. Reimbursement scenario
7.5.10.5. Italy Drug Delivery Devices Market Estimates and Forecasts, 2021-2033 (USD Million)
7.5.11. Spain
7.5.11.1. Key Country Dynamics
7.5.11.2. Competitive Scenario
7.5.11.3. Regulatory Framework
7.5.11.4. Reimbursement scenario
7.5.11.5. Spain Drug Delivery Devices Market Estimates and Forecasts, 2021-2033 (USD Million)
7.5.12. Denmark
7.5.12.1. Key Country Dynamics
7.5.12.2. Competitive Scenario
7.5.12.3. Regulatory Framework
7.5.12.4. Reimbursement scenario
7.5.12.5. Denmark Drug Delivery Devices Market Estimates and Forecasts, 2021-2033 (USD Million)
7.5.13. Sweden
7.5.13.1. Key Country Dynamics
7.5.13.2. Competitive Scenario
7.5.13.3. Regulatory Framework
7.5.13.4. Reimbursement scenario
7.5.13.5. Sweden Drug Delivery Devices Market Estimates and Forecasts, 2021-2033 (USD Million)
7.5.14. Norway
7.5.14.1. Key Country Dynamics
7.5.14.2. Competitive Scenario
7.5.14.3. Regulatory Framework
7.5.14.4. Reimbursement scenario
7.5.14.5. Norway Drug Delivery Devices Market Estimates and Forecasts, 2021-2033 (USD Million)
7.6. Asia-Pacific
7.6.1. Asia-Pacific Drug Delivery Devices Market Estimates and Forecasts, 2021-2033 (USD Million)
7.6.2. Japan
7.6.2.1. Key Country Dynamics
7.6.2.2. Competitive Scenario
7.6.2.3. Regulatory Framework
7.6.2.4. Reimbursement scenario
7.6.2.5. Japan Drug Delivery Devices Market Estimates and Forecasts, 2021-2033 (USD Million)
7.6.3. China
7.6.3.1. Key Country Dynamics
7.6.3.2. Competitive Scenario
7.6.3.3. Regulatory Framework
7.6.3.4. Reimbursement scenario
7.6.3.5. China Drug Delivery Devices Market Estimates and Forecasts, 2021-2033 (USD Million)
7.6.4. India
7.6.4.1. Key Country Dynamics
7.6.4.2. Competitive Scenario
7.6.4.3. Regulatory Framework
7.6.4.4. Reimbursement scenario
7.6.4.5. India Drug Delivery Devices Market Estimates and Forecasts, 2021-2033 (USD Million)
7.6.5. South Korea
7.6.5.1. Key Country Dynamics
7.6.5.2. Competitive Scenario
7.6.5.3. Regulatory Framework
7.6.5.4. Reimbursement scenario
7.6.5.5. South Korea Drug Delivery Devices Market Estimates and Forecasts, 2021-2033 (USD Million)
7.6.6. Australia
7.6.6.1. Key Country Dynamics
7.6.6.2. Competitive Scenario
7.6.6.3. Regulatory Framework
7.6.6.4. Reimbursement scenario
7.6.6.5. Australia Drug Delivery Devices Market Estimates and Forecasts, 2021-2033 (USD Million)
7.6.7. Thailand
7.6.7.1. Key Country Dynamics
7.6.7.2. Competitive Scenario
7.6.7.3. Regulatory Framework
7.6.7.4. Reimbursement scenario
7.6.7.5. Thailand Drug Delivery Devices Market Estimates and Forecasts, 2021-2033 (USD Million)
7.7. Latin America
7.7.1. Latin America Drug Delivery Devices Market Estimates and Forecasts, 2021-2033 (USD Million)
7.7.2. Brazil
7.7.2.1. Key Country Dynamics
7.7.2.2. Competitive Scenario
7.7.2.3. Regulatory Framework
7.7.2.4. Reimbursement scenario
7.7.2.5. Brazil Drug Delivery Devices Market Estimates and Forecasts, 2021-2033 (USD Million)
7.7.3. Argentina
7.7.3.1. Key Country Dynamics
7.7.3.2. Competitive Scenario
7.7.3.3. Regulatory Framework
7.7.3.4. Reimbursement scenario
7.7.3.5. Argentina Drug Delivery Devices Market Estimates and Forecasts, 2021-2033 (USD Million)
7.8. Middle East & Africa
7.8.1. Middle East & Africa Drug Delivery Devices Market Estimates and Forecasts, 2021-2033 (USD Million)
7.8.2. South Africa
7.8.2.1. Key Country Dynamics
7.8.2.2. Competitive Scenario
7.8.2.3. Regulatory Framework
7.8.2.4. Reimbursement scenario
7.8.2.5. South Africa Drug Delivery Devices Market Estimates and Forecasts, 2021-2033 (USD Million)
7.8.3. Saudi Arabia
7.8.3.1. Key Country Dynamics
7.8.3.2. Competitive Scenario
7.8.3.3. Regulatory Framework
7.8.3.4. Reimbursement scenario
7.8.3.5. Saudi Arabia Drug Delivery Devices Market Estimates and Forecasts, 2021-2033 (USD Million)
7.8.4. UAE
7.8.4.1. Key Country Dynamics
7.8.4.2. Competitive Scenario
7.8.4.3. Regulatory Framework
7.8.4.4. Reimbursement scenario
7.8.4.5. UAE Drug Delivery Devices Market Estimates and Forecasts, 2021-2033 (USD Million)
7.8.5. Kuwait
7.8.5.1. Key Country Dynamics
7.8.5.2. Competitive Scenario
7.8.5.3. Regulatory Framework
7.8.5.4. Reimbursement scenario
7.8.5.5. Kuwait Drug Delivery Devices Market Estimates and Forecasts, 2021-2033 (USD Million)
Chapter 8. Competitive Landscape
8.1. Market Participant Categorization
8.2. Key Company Profiles
8.2.1. Gerresheimer AG
8.2.1.1. Company overview
8.2.1.2. Financial performance
8.2.1.3. Product benchmarking
8.2.1.4. Strategic initiatives
8.2.2. W. L. Gore & Associates, Inc.
8.2.2.1. Company overview
8.2.2.2. Financial performance
8.2.2.3. Product benchmarking
8.2.2.4. Strategic initiatives
8.2.3. Abbott
8.2.3.1. Company overview
8.2.3.2. Financial performance
8.2.3.3. Product benchmarking
8.2.3.4. Strategic initiatives
8.2.4. Terumo Medical Corporation
8.2.4.1. Company overview
8.2.4.2. Financial performance
8.2.4.3. Product benchmarking
8.2.4.4. Strategic initiatives
8.2.5. Stryker
8.2.5.1. Company overview
8.2.5.2. Financial performance
8.2.5.3. Product benchmarking
8.2.5.4. Strategic initiatives
8.2.6. Medtronic
8.2.6.1. Company overview
8.2.6.2. Financial performance
8.2.6.3. Product benchmarking
8.2.6.4. Strategic initiatives
8.2.7. Boston Scientific Corporation
8.2.7.1. Company overview
8.2.7.2. Financial performance
8.2.7.3. Product benchmarking
8.2.7.4. Strategic initiatives
8.2.8. Novartis AG
8.2.8.1. Company overview
8.2.8.2. Financial performance
8.2.8.3. Product benchmarking
8.2.8.4. Strategic initiatives
8.2.9. Becton, Dickinson and Company
8.2.9.1. Company overview
8.2.9.2. Financial performance
8.2.9.3. Product benchmarking
8.2.9.4. Strategic initiatives
8.2.10. Teleflex Incorporated
8.2.10.1. Company overview
8.2.10.2. Financial performance
8.2.10.3. Product benchmarking
8.2.10.4. Strategic initiatives
List of Tables
Table 1 List of Secondary Sources
Table 2 List of Abbreviations
Table 3 North America drug delivery devices market, by country, 2021-2033 (USD Billion)
Table 4 North America drug delivery devices market, by product, 2021-2033 (USD Billion)
Table 5 North America drug delivery devices market, by application, 2021-2033 (USD Billion)
Table 6 North America drug delivery devices market, by end-use, 2021-2033 (USD Billion)
Table 7 US drug delivery devices market, by product, 2021-2033 (USD Billion)
Table 8 US drug delivery devices market, by application, 2021-2033 (USD Billion)
Table 9 US drug delivery devices market, by end-use, 2021-2033 (USD Billion)
Table 10 Canada drug delivery devices market, by product, 2021-2033 (USD Billion)
Table 11 Canada drug delivery devices market, by application, 2021-2033 (USD Billion)
Table 12 Canada drug delivery devices market, by end-use, 2021-2033 (USD Billion)
Table 13 Mexico drug delivery devices market, by product, 2021-2033 (USD Billion)
Table 14 Mexico drug delivery devices market, by application, 2021-2033 (USD Billion)
Table 15 Mexico drug delivery devices market, by end-use, 2021-2033 (USD Billion)
Table 16 Europe drug delivery devices market, by region, 2021-2033 (USD Billion)
Table 17 Europe drug delivery devices market, by product, 2021-2033 (USD Billion)
Table 18 Europe drug delivery devices market, by application, 2021-2033 (USD Billion)
Table 19 Europe drug delivery devices market, by end-use, 2021-2033 (USD Billion)
Table 20 Germany drug delivery devices market, by product, 2021-2033 (USD Billion)
Table 21 Germany drug delivery devices market, by application, 2021-2033 (USD Billion)
Table 22 Germany drug delivery devices market, by end-use, 2021-2033 (USD Billion)
Table 23 UK drug delivery devices market, by product, 2021-2033 (USD Billion)
Table 24 UK drug delivery devices market, by application, 2021-2033 (USD Billion)
Table 25 UK drug delivery devices market, by end-use, 2021-2033 (USD Billion)
Table 26 France drug delivery devices market, by product, 2021-2033 (USD Billion)
Table 27 France drug delivery devices market, by application, 2021-2033 (USD Billion)
Table 28 France drug delivery devices market, by end-use, 2021-2033 (USD Billion)
Table 29 Italy drug delivery devices market, by product, 2021-2033 (USD Billion)
Table 30 Italy drug delivery devices market, by application, 2021-2033 (USD Billion)
Table 31 Italy drug delivery devices market, by end-use, 2021-2033 (USD Billion)
Table 32 Spain drug delivery devices market, by product, 2021-2033 (USD Billion)
Table 33 Spain drug delivery devices market, by application, 2021-2033 (USD Billion)
Table 34 Spain drug delivery devices market, by end-use, 2021-2033 (USD Billion)
Table 35 Denmark drug delivery devices market, by product, 2021-2033 (USD Billion)
Table 36 Denmark drug delivery devices market, by application, 2021-2033 (USD Billion)
Table 37 Denmark drug delivery devices market, by end-use, 2021-2033 (USD Billion)
Table 38 Sweden drug delivery devices market, by product, 2021-2033 (USD Billion)
Table 39 Sweden drug delivery devices market, by application, 2021-2033 (USD Billion)
Table 40 Sweden drug delivery devices market, by end-use, 2021-2033 (USD Billion)
Table 41 Norway drug delivery devices market, by product, 2021-2033 (USD Billion)
Table 42 Norway drug delivery devices market, by application, 2021-2033 (USD Billion)
Table 43 Norway drug delivery devices market, by end-use, 2021-2033 (USD Billion)
Table 44 APAC drug delivery devices market, by region, 2021-2033 (USD Billion)
Table 45 APAC drug delivery devices market, by product, 2021-2033 (USD Billion)
Table 46 APAC drug delivery devices market, by application, 2021-2033 (USD Billion)
Table 47 APAC drug delivery devices market, by end-use, 2021-2033 (USD Billion)
Table 48 China drug delivery devices market, by product, 2021-2033 (USD Billion)
Table 49 China drug delivery devices market, by application, 2021-2033 (USD Billion)
Table 50 China drug delivery devices market, by end-use, 2021-2033 (USD Billion)
Table 51 Japan drug delivery devices market, by product, 2021-2033 (USD Billion)
Table 52 Japan drug delivery devices market, by application, 2021-2033 (USD Billion)
Table 53 Japan drug delivery devices market, by end-use, 2021-2033 (USD Billion)
Table 54 India drug delivery devices market, by product, 2021-2033 (USD Billion)
Table 55 India drug delivery devices market, by application, 2021-2033 (USD Billion)
Table 56 India drug delivery devices market, by end-use, 2021-2033 (USD Billion)
Table 57 Thailand drug delivery devices market, by product, 2021-2033 (USD Billion)
Table 58 Thailand drug delivery devices market, by application, 2021-2033 (USD Billion)
Table 59 Thailand drug delivery devices market, by end-use, 2021-2033 (USD Billion)
Table 60 South Korea drug delivery devices market, by product, 2021-2033 (USD Billion)
Table 61 South Korea drug delivery devices market, by application, 2021-2033 (USD Billion)
Table 62 South Korea drug delivery devices market, by end-use, 2021-2033 (USD Billion)
Table 63 Australia drug delivery devices market, by product, 2021-2033 (USD Billion)
Table 64 Australia drug delivery devices market, by application, 2021-2033 (USD Billion)
Table 65 Australia drug delivery devices market, by end-use, 2021-2033 (USD Billion)
Table 66 Latin America drug delivery devices market, by region, 2021-2033 (USD Billion)
Table 67 Latin America drug delivery devices market, by product, 2021-2033 (USD Billion)
Table 68 Latin America drug delivery devices market, by application, 2021-2033 (USD Billion)
Table 69 Latin America drug delivery devices market, by end-use, 2021-2033 (USD Billion)
Table 70 Brazil drug delivery devices market, by product, 2021-2033 (USD Billion)
Table 71 Brazil drug delivery devices market, by application, 2021-2033 (USD Billion)
Table 72 Brazil drug delivery devices market, by end-use, 2021-2033 (USD Billion)
Table 73 Argentina drug delivery devices market, by product, 2021-2033 (USD Billion)
Table 74 Argentina drug delivery devices market, by application, 2021-2033 (USD Billion)
Table 75 Argentina drug delivery devices market, by end-use, 2021-2033 (USD Billion)
Table 76 Middle East and Africa drug delivery devices market, by region, 2021-2033 (USD Billion)
Table 77 Middle East and Africa drug delivery devices market, by product, 2021-2033 (USD Billion)
Table 78 Middle East and Africa drug delivery devices market, by application, 2021-2033 (USD Billion)
Table 79 Middle East and Africa drug delivery devices market, by end-use, 2021-2033 (USD Billion)
Table 80 South Africa drug delivery devices market, by product, 2021-2033 (USD Billion)
Table 81 South Africa drug delivery devices market, by application, 2021-2033 (USD Billion)
Table 82 South Africa drug delivery devices market, by end-use, 2021-2033 (USD Billion)
Table 83 Saudi Arabia drug delivery devices market, by product, 2021-2033 (USD Billion)
Table 84 Saudi Arabia drug delivery devices market, by application, 2021-2033 (USD Billion)
Table 85 Saudi Arabia drug delivery devices market, by end-use, 2021-2033 (USD Billion)
Table 86 UAE drug delivery devices market, by product, 2021-2033 (USD Billion)
Table 87 UAE drug delivery devices market, by application, 2021-2033 (USD Billion)
Table 88 UAE drug delivery devices market, by end-use, 2021-2033 (USD Billion)
Table 89 Kuwait drug delivery devices market, by product, 2021-2033 (USD Billion)
Table 90 Kuwait drug delivery devices market, by application, 2021-2033 (USD Billion)
Table 91 Kuwait drug delivery devices market, by end-use, 2021-2033 (USD Billion)
List of Figures
Figure 1 Information Procurement
Figure 2 Primary Research Pattern
Figure 3 Market Research Approaches
Figure 4 Value Chain-Based Sizing & Forecasting
Figure 5 Market Formulation & Validation
Figure 6 Drug delivery devices market segmentation
Figure 7 Market driver analysis (Current & future impact)
Figure 8 Market restraint analysis (Current & future impact)
Figure 9 SWOT Analysis, by Factor (Political & Legal, Economic and Technological)
Figure 10 Porter’s Five Forces Analysis
Figure 11 Drug delivery devices market, Product outlook key takeaways (USD Million)
Figure 12 Drug delivery devices market Product movement analysis 2025 & 2033 (USD Million)
Figure 13 Inhalers market revenue estimates and forecasts, 2021-2033 (USD Million)
Figure 14 Metered-dose inhalers (MDIs) market revenue estimates and forecasts, 2021-2033 (USD Million)
Figure 15 Dry powder inhalers (DPIs) market revenue estimates and forecasts, 2021-2033 (USD Million)
Figure 16 Others market revenue estimates and forecasts, 2021-2033 (USD Million)
Figure 17 Injection devices market revenue estimates and forecasts, 2021-2033 (USD Million)
Figure 18 Prefilled syringes market revenue estimates and forecasts, 2021-2033 (USD Million)
Figure 19 Auto-injectors market revenue estimates and forecasts, 2021-2033 (USD Million)
Figure 20 Pen injectors market revenue estimates and forecasts, 2021-2033 (USD Million)
Figure 21 Needle-free injectors market revenue estimates and forecasts, 2021-2033 (USD Million)
Figure 22 Wearable injectors market revenue estimates and forecasts, 2021-2033 (USD Million)
Figure 23 Implants market revenue estimates and forecasts, 2021-2033 (USD Million)
Figure 24 Contraceptive implants market revenue estimates and forecasts, 2021-2033 (USD Million)
Figure 25 Drug-eluting stents market revenue estimates and forecasts, 2021-2033 (USD Million)
Figure 26 Biodegradable implants market revenue estimates and forecasts, 2021-2033 (USD Million)
Figure 27 Topical delivery system market revenue estimates and forecasts, 2021-2033 (USD Million)
Figure 28 Creams market revenue estimates and forecasts, 2021-2033 (USD Million)
Figure 29 Gels market revenue estimates and forecasts, 2021-2033 (USD Million)
Figure 30 Ointments market revenue estimates and forecasts, 2021-2033 (USD Million)
Figure 31 Oral delivery system market revenue estimates and forecasts, 2021-2033 (USD Million)
Figure 32 Controlled-release tablets and capsules market revenue estimates and forecasts, 2021-2033 (USD Million)
Figure 33 Buccal and sublingual tablets market revenue estimates and forecasts, 2021-2033 (USD Million)
Figure 34 Occular delivery system market revenue estimates and forecasts, 2021-2033 (USD Million)
Figure 35 Nebulizers market revenue estimates and forecasts, 2021-2033 (USD Million)
Figure 36 Transdermal patches market revenue estimates and forecasts, 2021-2033 (USD Million)
Figure 37 Infusion pumps market revenue estimates and forecasts, 2021-2033 (USD Million)
Figure 38 Drug delivery devices market, application outlook key takeaways (USD Million)
Figure 39 Drug delivery devices market application movement analysis 2025 & 2033 (USD Million)
Figure 40 Oncology market revenue estimates and forecasts, 2021-2033 (USD Million)
Figure 41 Infectious diseases market revenue estimates and forecasts, 2021-2033 (USD Million)
Figure 42 Respiratory diseases market revenue estimates and forecasts, 2021-2033 (USD Million)
Figure 43 Diabetes market revenue estimates and forecasts, 2021-2033 (USD Million)
Figure 44 Cardiovascular diseases market revenue estimates and forecasts, 2021-2033 (USD Million)
Figure 45 Autoimmune diseases market revenue estimates and forecasts, 2021-2033 (USD Million)
Figure 46 Central nervous system disorders market revenue estimates and forecasts, 2021-2033 (USD Million)
Figure 47 Others market revenue estimates and forecasts, 2021-2033 (USD Million)
Figure 48 Drug delivery devices market, end use outlook key takeaways (USD Million)
Figure 49 Drug delivery devices market, end use movement analysis 2025 & 2033 (USD Million)
Figure 50 Hospitals market revenue estimates and forecasts, 2021-2033 (USD Million)
Figure 51 Diagnostic centers market revenue estimates and forecasts, 2021-2033 (USD Million)
Figure 52 Ambulatory surgery centers/clinics market, application outlook key takeaways (USD Million)
Figure 53 Home care settings market revenue estimates and forecasts, 2021-2033 (USD Million)
Figure 54 Others market revenue estimates and forecasts, 2021-2033 (USD Million)
Figure 55 Drug delivery devices market: Regional key takeaways (USD Million)
Figure 56 Drug delivery devices market regional outlook, 2025 & 2033, USD Million
Figure 57 North America drug delivery devices estimates and forecasts, 2021-2033 (USD Million)
Figure 58 US drug delivery devices market estimates and forecasts, 2021-2033 (USD Million)
Figure 59 Canada drug delivery devices market estimates and forecasts, 2021-2033 (USD Million)
Figure 60 Mexico drug delivery devices market estimates and forecasts, 2021-2033 (USD Million)
Figure 61 Europe drug delivery devices market estimates and forecasts, 2021-2033 (USD Million)
Figure 62 UK drug delivery devices market estimates and forecasts, 2021-2033 (USD Million)
Figure 63 Germany drug delivery devices market estimates and forecasts, 2021-2033 (USD Million)
Figure 64 France drug delivery devices market estimates and forecasts, 2021-2033 (USD Million)
Figure 65 Spain drug delivery devices market estimates and forecasts, 2021-2033 (USD Million)
Figure 66 Italy drug delivery devices market estimates and forecasts, 2021-2033 (USD Million)
Figure 67 Sweden drug delivery devices market estimates and forecasts, 2021-2033 (USD Million)
Figure 68 Norway drug delivery devices market estimates and forecasts, 2021-2033 (USD Million)
Figure 69 Denmark drug delivery devices market estimates and forecasts, 2021-2033 (USD Million)
Figure 70 Asia-Pacific drug delivery devices market estimates and forecasts, 2021-2033 (USD Million)
Figure 71 China drug delivery devices market estimates and forecasts, 2021-2033 (USD Million)
Figure 72 Japan drug delivery devices market estimates and forecasts, 2021-2033 (USD Million)
Figure 73 India drug delivery devices market estimates and forecasts, 2021-2033 (USD Million)
Figure 74 South Korea drug delivery devices market estimates and forecasts, 2021-2033 (USD Million)
Figure 75 Australia drug delivery devices market estimates and forecasts, 2021-2033 (USD Million)
Figure 76 Thailand drug delivery devices market estimates and forecasts, 2021-2033 (USD Million)
Figure 77 Latin America drug delivery devices market estimates and forecasts, 2021-2033 (USD Million)
Figure 78 Brazil drug delivery devices market estimates and forecasts, 2021-2033 (USD Million)
Figure 79 Argentina drug delivery devices market estimates and forecasts, 2021-2033 (USD Million)
Figure 80 Middle East and Africa drug delivery devices market estimates and forecasts, 2021-2033 (USD Million)
Figure 81 South Africa drug delivery devices market estimates and forecasts, 2021-2033 (USD Million)
Figure 82 Saudi Arabia drug delivery devices market estimates and forecasts, 2021-2033 (USD Million)
Figure 83 UAE drug delivery devices market estimates and forecasts, 2021-2033 (USD Million)
Figure 84 Kuwait drug delivery devices market estimates and forecasts, 2021-2033 (USD Million)
Figure 85 List of key emerging company’s/distribution channel disruptors/innovators

Companies Mentioned

The companies profiled in this Drug Delivery Devices market report include:
  • Gerresheimer AG
  • W. L. Gore & Associates, Inc.
  • Abbott
  • Terumo Medical Corporation
  • Stryker
  • Medtronic
  • Boston Scientific Corporation
  • Novartis AG
  • Becton, Dickinson and Company
  • Teleflex Incorporated

Table Information

Report AttributeDetails
No. of Pages200
PublishedDecember 2025
Forecast Period2025 - 2033
Estimated Market Value ( USD ) in 2025 $ 463.8 Billion
Forecasted Market Value ( USD ) by 2033 $ 841.4 Billion
Compound Annual Growth Rate7.8%
Regions CoveredGlobal
No. of Companies Mentioned11

Related Topics

Related Reports

Implantable Drug Delivery Devices Market 2025-2033 - Product Image

Implantable Drug Delivery Devices Market 2025-2033

  • Report
  • 144 Pages
  • Global
From
Connected Drug Delivery Devices Market Size, Share, Trends, and Forecast by Product, End User, Technology, and Region, 2025-2033 - Product Image

Connected Drug Delivery Devices Market Size, Share, Trends, and Forecast by Product, End User, Technology, and Region, 2025-2033

  • Report
  • 140 Pages
  • Global
From
Targeted Drug Delivery Device Market Industry Trends and Global Forecasts to 2035: Distribution by Type of Device, Target Organ, Type of Therapy Delivered, Route of Administration, Therapeutic Area, Key Geographical Regions, Leading Players and Sales Forecast - Product Image

Targeted Drug Delivery Device Market Industry Trends and Global Forecasts to 2035: Distribution by Type of Device, Target Organ, Type of Therapy Delivered, Route of Administration, Therapeutic Area, Key Geographical Regions, Leading Players and Sales Forecast

  • Report
  • 275 Pages
  • Global
From
Drug Delivery Devices Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2020-2030F - Product Image

Drug Delivery Devices Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2020-2030F

  • Report
  • 185 Pages
  • Global
From
Connected Drug Delivery Devices Market Opportunity, Growth Drivers, Industry Trend Analysis, and Forecast 2025-2034 - Product Image

Connected Drug Delivery Devices Market Opportunity, Growth Drivers, Industry Trend Analysis, and Forecast 2025-2034

  • Report
  • 130 Pages
  • Global
From

About the Drug Delivery Device Market

The Drug Delivery Device market is a subset of the Medical Devices industry. It encompasses a wide range of products used to deliver drugs, such as inhalers, syringes, pumps, and patches. These devices are designed to provide precise and controlled drug delivery, allowing for improved patient outcomes. Drug delivery devices are used to treat a variety of conditions, including chronic diseases, cancer, and infectious diseases. The Drug Delivery Device market is highly competitive, with a number of large and small companies offering a variety of products. Some of the major players in the market include Becton Dickinson, Baxter International, Medtronic, and Johnson & Johnson. Other companies in the market include 3M, Novartis, and Merck. Show Less Read more

Copyright © 2002-2026 Research and Markets. All Rights Reserved.